Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 3
2001 8
2002 1
2003 1
2004 2
2005 2
2006 4
2007 2
2008 5
2009 3
2010 6
2011 1
2013 5
2015 3
2016 4
2017 8
2018 6
2019 3
2020 6
2021 5
2022 9
2024 6
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

94 results

Results by year

Filters applied: . Clear all
Page 1
Childhood thyroid carcinoma — single-centre experience.
Borysewicz-Sańczyk H, Pasławska M, Zdrodowska M, Sawicka B, Pomaski J, Handkiewicz-Junak D, Krajewska J, Czarniecka A, Jarząb B, Dzięcioł J, Bossowski A. Borysewicz-Sańczyk H, et al. Among authors: handkiewicz junak d. Endokrynol Pol. 2021;72(6):676-677. doi: 10.5603/EP.a2021.0086. Epub 2021 Oct 14. Endokrynol Pol. 2021. PMID: 34647614 Free article. English. No abstract available.
EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancer.
Poeppel TD, Handkiewicz-Junak D, Andreeff M, Becherer A, Bockisch A, Fricke E, Geworski L, Heinzel A, Krause BJ, Krause T, Mitterhauser M, Sonnenschein W, Bodei L, Delgado-Bolton RC, Gabriel M. Poeppel TD, et al. Among authors: handkiewicz junak d. Eur J Nucl Med Mol Imaging. 2018 May;45(5):824-845. doi: 10.1007/s00259-017-3900-4. Epub 2017 Dec 12. Eur J Nucl Med Mol Imaging. 2018. PMID: 29234845 Free article.
Polish diagnostic and therapeutic recommendations for adrenocortical carcinoma.
Handkiewicz-Junak D, Dedecjus M, Ambroziak U, Barczyński M, Bednarek-Papierska L, Chmielik E, Cichocki A, Czarniecka A, Ćwikła J, Hasse-Lazar K, Hubalewska-Dydejczyk A, Januszkiewicz-Caulier J, Jarząb B, Kamiński G, Karbownik-Lewińska M, Kolasińska-Ćwikła A, Koperski Ł, Kos-Kudła B, Kotecka-Blicharz A, Kowalska A, Krajewska J, Królicki L, Lewiński A, Michałowska I, Oczko-Wojciechowska M, Ruchała M, Syrenicz A, Tysarowski A, Ziółkowska B, Żyłka A. Handkiewicz-Junak D, et al. Endokrynol Pol. 2024;75(4):339-358. doi: 10.5603/ep.101677. Endokrynol Pol. 2024. PMID: 39279304 Free article.
Final overall survival and safety analyses of the phase III PSMAfore trial of [177Lu]Lu-PSMA-617 versus change of androgen receptor pathway inhibitor in taxane-naive patients with metastatic castration-resistant prostate cancer.
Fizazi K, Chi KN, Shore ND, Herrmann K, de Bono JS, Castellano D, Piulats JM, Fléchon A, Wei XX, Mahammedi H, Roubaud G, Fleming M, Haas T, Ghebremariam S, Kreisl TN, Rajagopalan S, Sartor O, Morris MJ; PSMAfore Investigators. Fizazi K, et al. Ann Oncol. 2025 Jul 17:S0923-7534(25)00852-X. doi: 10.1016/j.annonc.2025.07.003. Online ahead of print. Ann Oncol. 2025. PMID: 40680993 Free PMC article.
Early Diagnosis of Low-Risk Papillary Thyroid Cancer Results Rather in Overtreatment Than a Better Survival.
Krajewska J, Kukulska A, Oczko-Wojciechowska M, Kotecka-Blicharz A, Drosik-Rutowicz K, Haras-Gil M, Jarzab B, Handkiewicz-Junak D. Krajewska J, et al. Among authors: handkiewicz junak d. Front Endocrinol (Lausanne). 2020 Oct 6;11:571421. doi: 10.3389/fendo.2020.571421. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33123090 Free PMC article. Review.
Sorafenib for the treatment of thyroid cancer: an updated review.
Krajewska J, Handkiewicz-Junak D, Jarzab B. Krajewska J, et al. Among authors: handkiewicz junak d. Expert Opin Pharmacother. 2015 Mar;16(4):573-83. doi: 10.1517/14656566.2015.1005601. Epub 2015 Jan 21. Expert Opin Pharmacother. 2015. PMID: 25605317 Review.
The role of FDG PET assessment in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 inhibitors in the second-line setting.
Kubeczko M, Polakiewicz-Gilowska A, D'Amico A, Chrabański O, Świderska K, Chmielik E, Blamek S, Handkiewicz-Junak D, Jarząb M. Kubeczko M, et al. Among authors: handkiewicz junak d. Front Oncol. 2024 Dec 3;14:1454844. doi: 10.3389/fonc.2024.1454844. eCollection 2024. Front Oncol. 2024. PMID: 39697231 Free PMC article.
94 results